Photos: Ion Houston's latest art installations tackle tech, social issues

eye on the ion

Revealed at an event earlier this month, the Ion is now home to installations by Houston-based artists Christopher Blay and Kill Joy, which play on the traditional window displays the building hosted for years as the historic Sears Building. Photo courtesy of Marc Furi Creative/the Ion

Two new art installations at the Ion speak to the building's past and its potential future.

Revealed at an event earlier this month, the innovation hub developed by Rice University is now home to installations by Houston-based artists Christopher Blay and Kill Joy, which play on the traditional window displays the building hosted for years as the historic Sears Building.

The pieces are part of the Ion's Eye on Art program, according to a release. Each was selected by the Ion and Ion District Art Advisory Council with support from Piper Faust.

"Innovation and art have a lot more in common than you might think. Many of our local artists learn how to use emerging technologies to create their pieces and hone their craft,” Jan E. Odegard, executive director of the Ion, says in a statement. “Creativity plays a vital role in fostering innovation and we’re honored to provide artists like Christopher and Kill Joy with a platform to serve as an inspiration for the entire innovation ecosystem here at the Ion.”

Blay, who's an artist, writer and currently serves as the chief curator of the Houston Museum of African American Culture, created his installation in collaboration with the Ion Prototyping Lab. Using canvases and wood frames, the installation depicts slaving vessels and spaceships to "symbolizes where the Black community has been and where they are going," according to the Ion.

The installation is part of Blay's latest body of work, “The SpLaVCe Program."

Joy's work focuses on environmental and social justice. Her installation at the Ion, “Creation, Current, Solution," uses animated puppets inspired by Filipino folklore to explore the intersection of technology and sustainable living.

Blay and Joy's installations will be on display for the next six months, and will rotate out to feature other Houston-based artists' work.

The Ion first launched the The Eye On Art Program in March 2022. The debut displays included Lina Dib’s over-the-top kitsch “Self-Portrait in the Garden” and Preston Gaines' multi-sensory “Fantasy Landscape.” The second rotation featured Lisa Morales and Stacey Gresell’s “The Collective Hive” and “Exploración Orgánica” by Maria Rodriguez, Miriam Mireles, Bryce Saucier, Timothy Hudson, and Victoria Armenta: “Exploración Orgánica”

Earlier this summer, the Ion also announced that it would launch its official workforce development partner’s 12- to 15- week technology skills training courses this fall.

Click through photos from the new installation below.

“The SpLaVCe Program" by Christopher Blay

Photo courtesy of Marc Furi Creative/the Ion

From Your Site Articles
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston edtech company closes oversubscribed $3M seed round

fresh funding

Houston-based edtech company TrueLeap Inc. closed an oversubscribed seed round last month.

The $3.3 million round was led by Joe Swinbank Family Limited Partnership, a venture capital firm based in Houston. Gamper Ventures, another Houston firm, also participated with additional strategic partners.

TrueLeap reports that the funding will support the large-scale rollout of its "edge AI, integrated learning systems and last-mile broadband across underserved communities."

“The last mile is where most digital transformation efforts break down,” Sandip Bordoloi, CEO and president of TrueLeap, said in a news release. “TrueLeap was built to operate where bandwidth is limited, power is unreliable, and institutions need real systems—not pilots. This round allows us to scale infrastructure that actually works on the ground.”

True Leap works to address the digital divide in education through its AI-powered education, workforce systems and digital services that are designed for underserved and low-connectivity communities.

The company has created infrastructure in Africa, India and rural America. Just this week, it announced an agreement with the City of Kinshasa in the Democratic Republic of Congo to deploy a digital twin platform for its public education system that will allow provincial leaders to manage enrollment, staffing, infrastructure and performance with live data.

“What sets TrueLeap apart is their infrastructure mindset,” Joe Swinbank, General Partner at Joe Swinbank Family Limited Partnership, added in the news release. “They are building the physical and digital rails that allow entire ecosystems to function. The convergence of edge compute, connectivity, and services makes this a compelling global infrastructure opportunity.”

TrueLeap was founded by Bordoloi and Sunny Zhang and developed out of Born Global Ventures, a Houston venture studio focused on advancing immigrant-founded technology. It closed an oversubscribed pre-seed in 2024.

Texas space co. takes giant step toward lunar excavator deployment

Out of this world

Lunar exploration and development are currently hampered by the fact that the moon is largely devoid of necessary infrastructure, like spaceports. Such amenities need to be constructed remotely by autonomous vehicles, and making effective devices that can survive the harsh lunar surface long enough to complete construction projects is daunting.

Enter San Antonio-based Astroport Space Technologies. Founded in San Antonio in 2020, the company has become a major part of building plans beyond Earth, via its prototype excavator, and in early February, it completed an important field test of its new lunar excavator.

The new excavator is designed to function with California-based Astrolab's Flexible Logistics and Exploration (FLEX) rover, a highly modular vehicle that will perform a variety of functions on the surface of the moon.

In a recent demo, the Astroport prototype excavator successfully integrated with FLEX and proceeded to dig in a simulated lunar surface. The excavator collected an average of 207 lbs (94kg) of regolith (lunar surface dust) in just 3.5 minutes. It will need that speed to move the estimated 3,723 tons (3,378 tonnes) of regolith needed for a lunar spaceport.

After the successful test, both Astroport and Astrolab expressed confidence that the excavator was ready for deployment. "Leading with this successful excavator demo proves that our technology is no longer theoretical—it is operational," said Sam Ximenes, CEO of Astroport.

"This is the first of many implements in development that will turn Astrolab's FLEX rover into the 'Swiss Army Knife' of lunar construction. To meet the infrastructure needs of the emerging lunar economy, we must build the 'Port' before the 'Ship' arrives. By leveraging the FLEX platform, we are providing the Space Force, NASA, and commercial partners with a 'Shovel-Ready' construction capability to secure the lunar high ground."

"We are excited to provide the mobility backbone for Astroport's groundbreaking construction technology," said Jaret Matthews, CEO of Astrolab, in a release. "Astrolab is dedicated to establishing a viable lunar ecosystem. By combining our FLEX rover's versatility with Astroport's civil engineering expertise, we are delivering the essential capabilities required for a sustainable lunar economy."

---

This article originally appeared on CultureMap.com.

Houston biotech co. raises $11M to advance ALS drug development

drug money

Houston-based clinical-stage biotechnology company Coya Therapeutics (NASDAQ: COYA) has raised $11.1 million in a private investment round.

India-based pharmaceuticals company Dr. Reddy’s Laboratories Inc. led the round with a $10 million investment, according to a news release. New York-based investment firm Greenlight Capital, Coya’s largest institutional shareholder, contributed $1.1 million.

The funding was raised through a definitive securities purchase agreement for the purchase and sale of more than 2.5 million shares of Coya's common stock in a private placement at $4.40 per share.

Coya reports that it plans to use the proceeds to scale up manufacturing of low-dose interleukin-2 (IL-2), which is a component of its COYA 302 and will support the commercial readiness of the drug. COYA 302 enhances anti-inflammatory T cell function and suppresses harmful immune activity for treatment of Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Parkinson’s disease and Alzheimer’s disease.

The company received FDA acceptance for its investigational new drug application for COYA 302 for treating ALS and FTD this summer. Its ALSTARS Phase 2 clinical trial for ALS treatment launched this fall in the U.S. and Canada and has begun enrolling and dosing patients. Coya CEO Arun Swaminathan said in a letter to investors that the company also plans to advance its clinical programs for the drug for FTD therapy in 2026.

Coya was founded in 2021. The company merged with Nicoya Health Inc. in 2020 and raised $10 million in its series A the same year. It closed its IPO in January 2023 for more than $15 million. Its therapeutics uses innovative work from Houston Methodist's Dr. Stanley H. Appel.

View All Listings